Crystal structure of middle east respiratory syndrome coronavirus (mers-cov) 3cl protease inactive mutant c148a Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2022-08-24 Method: X-RAY DIFFRACTION Resolution: 2.5 Å Organism(s): Middle East Respiratory Syndrome-Related Coronavirus Sequences Data: 8E7T_A , 8E7T_B , 8E7T_C , 8E7T_D
Crystal structure of sars-cov-2 mpro mutant e166a with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-03 Method: X-RAY DIFFRACTION Resolution: 1.88 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9EL4_A , 9EL4_B
Crystal structure of sars-cov-2 mpro mutant e166v with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-05 Method: X-RAY DIFFRACTION Resolution: 1.62 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9ELV_A , 9ELV_B
Crystal structure of sars-cov-2 mpro mutant l50f e166v with pfizer intravenous inhibitor pf-00835231 Deposition Author(s): Schiffer, C.A. , Shaqra, A.M. , Zvornicanin, S.N.
Date: 2024-12-06 Method: X-RAY DIFFRACTION Resolution: 1.84 Å Organism(s): Severe Acute Respiratory Syndrome Coronavirus 2 Sequences Data: 9MEI_A , 9MEI_B